News | Endovascular Aortic Repair | November 21, 2018

Obese Patients Have More Post-Op Problems Following AAA Repair

Study finds obese patients have higher rates of renal failure and wound infection after endovascular abdominal aortic aneurysm repair

Obese Patients Have More Post-Op Problems Following AAA Repair

November 21, 2018 — New research in the December edition of the Journal of Vascular Surgery suggests significant increase in morbidities in obese patients after open surgery, but not after endovascular abdominal aortic aneurysm (AAA) repair.1

Researchers found that obese patients were more likely to have longer procedures and to lose more blood than those who were not obese, and obese patients were more likely to have post-operative problems such as renal failure or wound infections.

In this new study, researchers from Johns Hopkins University, led by vascular surgeon Mahmoud Malas, M.D., performed a retrospective analysis of prospectively collected data by the Vascular Quality Initiative (2003-2017). The aim of the study was comparing in-hospital outcomes in obese (body mass index >30) vs non-obese patients undergoing AAA repair.

“In this large national sample of an elective AAA cohort,” said Malas, “obese patients had similar in-hospital mortality compared with non-obese patients in both open and endovascular repairs. The results remained unchanged even after looking at different subclasses of obesity, including those with BMI >40.”

Previous work defining early outcomes after AAA in the obese has yielded conflicted results. Recent meta-analysis suggested the superiority of endovascular repair over open, but only four studies with relatively small numbers were included. Single-center studies have either corroborated this conclusion or failed to demonstrate a difference.

The new study ultimately evaluated 33,082 procedures including both:

  • Open repair (non-obese, n=4,604, obese, n=1,754); and

  • Endovascular repair (non-obese, n=18,338, obese, n=8,385).

Demographic analysis revealed that the obese patients, compared to the non-obese, were:

  • Younger (67.6 vs 70.3 years old);

  • Male (open repair, 76 percent vs 73 percent, endovascular repair, 82 percent vs 81 percent); and

  • More likely to have significant comorbid conditions (diabetes, hypertension, coronary artery disease, and congestive heart disease).

Evaluation of the operations revealed that the obese had:

  • Higher blood loss (open, 2,030 vs 1,617ml, endovascular 228 vs 207ml); and

  • Longer operations (open 259 vs 239 mins, endovascular 138 vs 134 mins).

With regards to outcomes, there was no difference in mortality between the groups for either repair method (open 3 percent vs 3 percent, endovascular 0.5 percent vs 0.6 percent).

However, following open repair, the obese patients had higher odds of developing:

  • Renal failure (1.33 odds ratio); and

  • Wound infection (1.75 odds ratio).

“Wound infection is a common complication seen among obese patients undergoing all surgical procedures. Even after adjusting for comorbid conditions, the obese had 75 percent higher odds of wound infection following open repair, with the highest rates observed in the more severely obese patients,” noted Malas.

“In this study open repair showed increased risk of all in-hospital complications compared with endovascular therapy for AAA,” Malas said, “corroborating the known superiority of endovascular repair over open repair seen in the literature.”

While weight reduction itself would be considered important, this is not always possible in cases where more urgent care is necessary, such as AAA. With the prevalence of significant obesity in the United States as high as 39.8 percent, understanding its impact on the outcomes of various medical procedures is key in delivering safe and cost-effective healthcare.

This research article is open source here through Jan. 31, 2019.

For more information: www.jvascsurg.org

Reference

1. Locham S., Rizwan M., Dakour-Aridi H., et al. Outcomes after elective abdominal aortic aneurysm repair in obese versus nonobese patients. Journal of Vascular Surgery, published online June 7, 2018. https://doi.org/10.1016/j.jvs.2018.03.414


Related Content

News | Cardiovascular Clinical Studies

April 24, 2024 —Hello Heart, a digital leader in preventive heart health, today announced results from its latest study ...

Home April 24, 2024
Home
News | Cardiovascular Clinical Studies

April 22, 2024 — Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, welcomes the ...

Home April 22, 2024
Home
News | Cardiovascular Clinical Studies

April 16, 2024 — CVRx, Inc., a commercial-stage medical device company, announced today the availability of additional ...

Home April 16, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — Transcatheter aortic valve replacement (TAVR) was found to bring no increased risks and was associated ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — People with a buildup of fatty atherosclerotic plaque in the heart’s arteries considered at risk of ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Patients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — One of the first studies to attempt to treat early-stage heart failure in patients with Type 2 diabetes ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — The investigational drug ninerafaxstat showed a good tolerability and safety profile, along with ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Administering tranexamic acid (TxA), a drug used to reduce bleeding during heart surgery, topically ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Using a web application to qualify individuals for treatment with a nonprescription statin closely ...

Home April 09, 2024
Home
Subscribe Now